SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-078676
Filing Date
2024-06-27
Accepted
2024-06-27 19:00:04
Documents
1
Period of Report
2024-06-26

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3912
  Complete submission text file 0000950170-24-078676.txt   5641
Mailing Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142 617-410-4650
Cullinan Therapeutics, Inc. (Issuer) CIK: 0001789972 (see all company filings)

IRS No.: 813867811 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address ONE MAIN STREET SUITE 520 CAMBRIDGE MA 02142
Business Address
Martin Anne-Marie (Reporting) CIK: 0001914495 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39856 | Film No.: 241080853